Effects of Speech-therapy in Hypertensive Patients

K

Klinik Arlesheim

Status

Completed

Conditions

Hypertension

Treatments

Behavioral: Anthroposophic speech therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT02681484
ATS1

Details and patient eligibility

About

Anthroposophic speech therapy (ATS) has been shown to positively influence heart rate variability (HRV) and heart rate - respiration coordination in healthy volunteers. This study was performed to learn more about such improvements and possible alteration in baroreflex sensitivity (BRS) in hypertensive patients, which characteristically differ in those regulatory parameters from normotensive patients

Full description

In this prospective, primarily pre-post study, patients received three ATS treatments in alternation with three control sessions (casual talking with the therapist). In order to perform HRV-analysis and BRS determination blood pressure and ECG were continuously recorded during the sessions. Changes in subjective well-being and perceived health were assessed by questionnaire before and after the various sessions (mood questionaire). Thirty-one patients participated in this study, the majority diagnosed with arterial hypertension (22 out of 31).

Enrollment

31 patients

Sex

All

Ages

20 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Indication for speech therapy
  • Willing and able to perform speech therapy
  • Out-patient treatment or planned hospitalisation for at least 14 days.
  • Diagnosed with hypertension (I 10, either on drug therapy or verified by 24h blood pressure measurements), with tension headache (G 44.2) or with anxiety (F 41) confirmed by the recruiting physician
  • No alteration in medication affecting HRV for the last 2 months before and during the study

Exclusion criteria

  • Comorbidity strongly influencing HRV
  • Too weak to participate in an active therapy
  • Pacemaker
  • Skin disease or allergies preventing the use of ECG electrodes

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Factorial Assignment

Masking

None (Open label)

31 participants in 2 patient groups

Hypertensive
Experimental group
Description:
Patients diagnosed with hypertension (I10, either on drug therapy or verified by 24h blood pressure measurements) administered to anthroposophic speech therapy (intervention).
Treatment:
Behavioral: Anthroposophic speech therapy
Normotensive
Active Comparator group
Description:
Patients diagnosed with tension headache (G 44.2) or anxiety disorders (F41) administered to anthroposophic speech therapy (intervention).
Treatment:
Behavioral: Anthroposophic speech therapy

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems